azathioprine has been researched along with Venous Thromboembolism in 4 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Venous Thromboembolism: Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sirolimus (rapamycin) is a potent anti-proliferative agent with immunosuppressive properties that is increasingly being used in solid-organ and hematopoietic stem cell transplantation." | 6.76 | Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation. ( Ahya, VN; Alex, CG; Arcasoy, SM; Bag, R; Baz, MA; Bhorade, S; Charbeneau, J; DeOliveira, NC; Durazo-Arvizu, R; Garrity, E; Krishnan, JA; Love, RB; McShane, PJ; Norwick, L; Seethamraju, H; Valentine, VG; Vigneswaran, WT, 2011) |
| "Sirolimus (rapamycin) is a potent anti-proliferative agent with immunosuppressive properties that is increasingly being used in solid-organ and hematopoietic stem cell transplantation." | 2.76 | Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation. ( Ahya, VN; Alex, CG; Arcasoy, SM; Bag, R; Baz, MA; Bhorade, S; Charbeneau, J; DeOliveira, NC; Durazo-Arvizu, R; Garrity, E; Krishnan, JA; Love, RB; McShane, PJ; Norwick, L; Seethamraju, H; Valentine, VG; Vigneswaran, WT, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, W | 1 |
| Shim, HH | 1 |
| Ng, SC | 1 |
| Liu, J | 1 |
| Inglis, C | 1 |
| Greveson, K | 1 |
| Baraty, B | 1 |
| Haifer, C | 1 |
| Leong, RWL | 1 |
| Thorell, SE | 1 |
| Gorodkin, R | 1 |
| Murray, D | 1 |
| Thachil, J | 1 |
| Bollen, L | 1 |
| Vande Casteele, N | 1 |
| Ballet, V | 1 |
| van Assche, G | 1 |
| Ferrante, M | 1 |
| Vermeire, S | 1 |
| Gils, A | 1 |
| Ahya, VN | 1 |
| McShane, PJ | 1 |
| Baz, MA | 1 |
| Valentine, VG | 1 |
| Arcasoy, SM | 1 |
| Love, RB | 1 |
| Seethamraju, H | 1 |
| Garrity, E | 1 |
| Alex, CG | 1 |
| Bag, R | 1 |
| DeOliveira, NC | 1 |
| Vigneswaran, WT | 1 |
| Charbeneau, J | 1 |
| Krishnan, JA | 1 |
| Durazo-Arvizu, R | 1 |
| Norwick, L | 1 |
| Bhorade, S | 1 |
1 trial available for azathioprine and Venous Thromboembolism
| Article | Year |
|---|---|
Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.
Topics: Azathioprine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; | 2011 |
3 other studies available for azathioprine and Venous Thromboembolism
| Article | Year |
|---|---|
A Global Survey of Gastroenterologists' Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas.
Topics: Antibodies, Monoclonal, Humanized; Azathioprine; Diarrhea; Directive Counseling; Endemic Diseases; G | 2018 |
Behcet's disease and refractory thrombosis.
Topics: Anticoagulants; Azathioprine; Behcet Syndrome; Drug Therapy, Combination; Female; Humans; Immunosupp | 2015 |
Thromboembolism as an important complication of inflammatory bowel disease.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; C | 2016 |